Angus Liu @Angus_Fierce
Biopharma follower @FiercePharma & @FierceBiotech. Medill MSJ 16 Joined November 2013-
Tweets104
-
Followers765
-
Following601
-
Likes48
More background on the FDA's first-of-its-kind, confirmatory trial-related CRL for Regeneron. fiercebiotech.com/biotech/what-d…
Just imagine this: Every case of an important update being buried in an SEC filing is fed to an AI somewhere fiercebiotech.com/biotech/modern…
Special report: CAR-T hype faces infrastructure reality check fiercepharma.com/pharma/mid-dec…
Novo Nordisk answers Eli Lilly's challenge in obesity treatment with its own head-to-head trial for a Wegovy combination against Zepbound. Details in story. fiercepharma.com/pharma/novo-no…
The FDA has approved Merck's Keytruda as part of a neoadjuvant-plus-adjuvant therapy for resectable non-small cell lung cancer. The label already includes overall survival data. fiercepharma.com/pharma/mercks-…
In the Breakthroughs category, we’ll recognize organizations, clinicians, researchers and others whose work has pushed the boundaries of knowledge and improved the lives of countless individuals. fiercepharma.com/fierce-50/fier… #Fierce50 #WeAreFierce
Merck and Moderna's phase 3 plan for their mRNA cancer vaccine is here. $MRK $MRNA fiercebiotech.com/biotech/merck-…
This week's The Top Line podcast from @FiercePharma includes a recap of the star-studded ADA meeting omny.fm/shows/the-top-…
Intercept Pharma enters restructuring mode as FDA rejects OCA again in NASH. fiercepharma.com/pharma/interce…
The Rubraca CRL was expected. But in what looks like a reprimand for Clovis' disobedience, FDA's now asking for FINAL OS analysis v. 50% maturity fiercepharma.com/pharma/fda-rej…
Beyond the prev. leaked ITT data, J&J/Legend also offered a look at CARTITUDE-4's per-protocol as-treated data, incl. Carvykti ORR/CR 99.4%/86.4% #ASCO23
Beyond the prev. leaked ITT data, J&J/Legend also offered a look at CARTITUDE-4's per-protocol as-treated data, incl. Carvykti ORR/CR 99.4%/86.4% #ASCO23
I see this Novartis' Kisqali v. Eli Lilly's Verzenio rivalry in early-stage HR+/HER2- breast cancer to potentially evolve into a Zejula vs. Lynparza situation in ovarian cancer. #ASCO23 fiercepharma.com/pharma/novarti…
I thought after covering cancer data for 4 years, I wouldn't have trouble pronouncing "statistically significant." I was wrong.
Fierce Pharma wants to hear your stories of the pandemic—in photographs—and together contribute to a place that stores the biopharma industry’s collective memory of COVID. fiercepharma.com/pharma/we-want…
"We do not regulate practice of medicine," FDA's oncology chief Rick Pazdur said in a perhaps defining moment during Friday's adcom on AstraZeneca's Lynparza in prostate cancer. fiercepharma.com/pharma/astraze…
Carvykti's ASCO debut was also my very first ASCO story
Carvykti's ASCO debut was also my very first ASCO story
Eli Lilly quietly unveiled a #Mounjaro head-to-head trial against Novo Nordisk's #Wegovy. It's game on between the two drugmakers in #obesity: fiercepharma.com/pharma/heavywe…
An end to Pluvicto's shortage could be in sight now that the FDA has quickly approved a Novartis radiotherapy manufacturing facility in New Jersey. fiercepharma.com/manufacturing/…
As Novartis works to commission new manufacturing sites, new patient starts have been put on hold as existing patients face treatment delays. loom.ly/isZVEKQ
This week on 'The Top Line', @Angus_Fierce and Michael Atkins, M.D., sat down to discuss a checklist that SITC released for running phase 3 cancer immunotherapy combination studies. Plus, the week's biggest headlines. tinyurl.com/43wvj528
Kyle LaHucik @ky_lahucik
3K Followers 2K Following reporting on the $, people & startups in biotech land @Endpts | [email protected] | askin Qs, joggin 26.2 | 🗞 📷 🌎 | XC + Track coach | 🏳️🌈
Jacob Plieth @JacobPlieth
26K Followers 285 Following Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
Kimberly Ha @pharmaprodigy
2K Followers 2K Following Founder, KKH Advisors // Strategic Communications. Biotech & Digital Health. Former @fticonsulting
Gwendolyn Wu @gwendolynawu
4K Followers 3K Following Reporting on drug discovery/VC @BioPharmaDive. Prev. @sfchronicle @houstonchron. Always @tblucsb @aaja @cspaworkshop, Chrome tab hoarder. 📸: @hannahlchinn
Ron Leuty @rleuty_biotech
11K Followers 2K Following #Biotech reporter @SFBusinessTimes; hardcore @Tigers fan; once rolled a 288. Tip me: [email protected], Signal or 415-722-2678. Also find me on Post.
Andrew Dunn @AndrewE_Dunn
10K Followers 2K Following Senior biopharma correspondent at @endpts | Previously @BusinessInsider @BioPharmaDive | Tips? DM or 978-577-5798 (Signal/text) [email protected]
Mandy Jackson @ScripMandy
6K Followers 778 Following I am Managing Editor, US Commercial News, for the Citeline Commercial publications Scrip and The Pink Sheet. Views expressed here are strictly my own.
Drew Armstrong @ArmstrongDrew
31K Followers 3K Following Executive Editor, Endpoints News (@endpts). Got a tip? DM me for my Signal handle.
Deborah Ifantides @DIfantides33744
20 Followers 3K Following
Thu Zupan @thu_zup
63 Followers 5K Following
Winona Giovinco @WinonaWinon
97 Followers 5K Following
Shanon Haen @haen_hae
83 Followers 5K Following
Mellissa Suman @MellissaSu1006
51 Followers 5K Following
Ruth Esparza @esparza_ru16764
90 Followers 3K Following
mb312q7my7q @d0stsl2bwxia9u
1 Followers 42 Following
Renae Helland @re_hella
72 Followers 5K Following
Tressa Bayman @BaymanTres12457
91 Followers 5K Following
Izzy Royster @IzzyRoyste79253
75 Followers 5K Following
Rhonda Curry @RhondaLeeCurry
370 Followers 791 Following Optimistic communicator for cancer research @SylvesterCancer Chapters include @UCLAHealth @dgsomucla @GonzagaU @fredhutch
Rachel Cohrs Zhang @rachelcohrs
6K Followers 3K Following Chief Washington Correspondent @statnews. Subscribe to D.C. Diagnosis: https://t.co/t19n377jX6 ✉️: [email protected]
Chelsea Rule @ChelseaRule7
10 Followers 124 Following Life Science and Healthcare Communication and Consulting @macdougallbio | Microbiology & Immunology Ph.D.
portlandoregon99 @providenceoreg
30 Followers 321 Following
Parthenia Treleven @PartheniaT64948
77 Followers 5K Following
Kady Havatone @KaHavat
27 Followers 5K Following
Katharine Kuprewicz @KatharineK43025
84 Followers 5K Following
Isla-grace Hanawalt @IslaGrac
88 Followers 5K Following
Lily-grace Parks @ParksLily36229
96 Followers 5K Following
Kacey Irr @KaceyI16845
70 Followers 5K Following
Cassandra Carothers @CassCarothers
901 Followers 3K Following Frontier Tech for humanity & planet @DepartureVC
LatM X @LatMonX
49 Followers 92 Following
Ostrohealth @ostrohealth
26 Followers 118 Following AI-powered technology for better consumer and HCP engagement 🚀 #pharma #tech #AI
11|TEN Innovation Par.. @11teninnovation
96 Followers 263 Following Helping businesses grow through the power of innovation ecosystems: 1+1=10 or 11|TEN #REALizingInnovation
ISCT @ISCTglobal
5K Followers 646 Following Driving the translation of cell & gene therapies for the benefit of patients worldwide.
Lizzette Faykosh @LizzeFayko
29 Followers 5K Following
Celestine Mannick @CelestMann
48 Followers 5K Following
Sylvie Nahhas @SylNahhas
52 Followers 5K Following
Rana Conlans @ran_conla
35 Followers 5K Following
Sarah Thailing @wordanista
255 Followers 2K Following Strategic biotech + life sciences communicator | Senior Director, Corporate Communications & IR at @PoseidaThera
lexon @lexon3333
150 Followers 1K Following
Reign Luers @luers38643
27 Followers 5K Following
Lilly Geffers @LillGeffe
35 Followers 5K Following
Kum Jhanson @JhansonKum33372
40 Followers 5K Following
Valeria Giebler @gieb_valeri
53 Followers 5K Following
Dana S @DanaS0877659128
3 Followers 37 Following
Apierion @apierion
93 Followers 262 Following We are revolutionizing healthcare payments and data exchange.
Victoria Fort @fortvictoria
43 Followers 229 Following
Chris Stevo @choostevo
147 Followers 5K Following
Kitty Winikoff @KittyWinik448
94 Followers 5K Following
Brad Loncar @bradloncar
69K Followers 365 Following #Biotech, Founder of @BiotechTVHQ, KC native, @univmiami hurricane.🧬🙌
Adam Feuerstein ✡�.. @adamfeuerstein
114K Followers 750 Following Reporter @statnews. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously.
Michael Gilman @michael_gilman
24K Followers 785 Following Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player, #immigrant. CEO @ArrakisTx. Just @gilman on...
Kyle LaHucik @ky_lahucik
3K Followers 2K Following reporting on the $, people & startups in biotech land @Endpts | [email protected] | askin Qs, joggin 26.2 | 🗞 📷 🌎 | XC + Track coach | 🏳️🌈
Jacob Plieth @JacobPlieth
26K Followers 285 Following Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
Matthew Herper @matthewherper
111K Followers 3K Following Writing and events at STAT. This is biology's century; Every data point has a face. ‘21 Polk Award. Mastodon: @[email protected]
Bertrand Delsuc @BertrandBio
16K Followers 253 Following Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design) & a bit of Bio :)
Kimberly Ha @pharmaprodigy
2K Followers 2K Following Founder, KKH Advisors // Strategic Communications. Biotech & Digital Health. Former @fticonsulting
John Carroll @JohnCendpts
70K Followers 94 Following Working journalist for 46 years, invented FierceBiotech, founded Endpoints News now majority-@FT owned. 201,000 subscribers. These are personal opinions.
Gwendolyn Wu @gwendolynawu
4K Followers 3K Following Reporting on drug discovery/VC @BioPharmaDive. Prev. @sfchronicle @houstonchron. Always @tblucsb @aaja @cspaworkshop, Chrome tab hoarder. 📸: @hannahlchinn
STAT @statnews
165K Followers 5K Following Reporting from the frontiers of health & medicine. Sign up for any of our 10 free newsletters here: https://t.co/CBx3GZBv31
Peter Kolchinsky @PeterKolchinsky
66K Followers 181 Following Managing Partner, RA Capital Management. We build & invest in biotech companies. Scientist. Author, The Great American Drug Deal. https://t.co/ARVLrrTQU4
ASCO @ASCO
147K Followers 2K Following Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
Ron Leuty @rleuty_biotech
11K Followers 2K Following #Biotech reporter @SFBusinessTimes; hardcore @Tigers fan; once rolled a 288. Tip me: [email protected], Signal or 415-722-2678. Also find me on Post.
John Maraganore 🇺�.. @JMaraganore
14K Followers 412 Following Founding CEO of @Alnylam. Pioneered RNAi therapeutics as a whole new class of medicines for patients. Now bioentrepreneur-at-large. Opinions are my own.
Allison DeAngelis @ADeAngelis_bio
5K Followers 890 Following Reporter covering biopharma startups and venture capital at @statnews. Formerly @thisisinsider and @bosbizjournal.
Andrew Dunn @AndrewE_Dunn
10K Followers 2K Following Senior biopharma correspondent at @endpts | Previously @BusinessInsider @BioPharmaDive | Tips? DM or 978-577-5798 (Signal/text) [email protected]
Madeleine Armstrong @ByMadeleineA
7K Followers 1K Following Senior reporter at @ApexOnco; cat lover; Croydon Harrier
Bruce Booth @LifeSciVC
50K Followers 731 Following Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
Jay Bhattacharya @DrJBhattacharya
502K Followers 6K Following Professor Stanford School of Medicine. MD, PhD. Health policy: infectious diseases, covid, health economics. Scientific freedom.
Vinay Prasad MD MPH @VPrasadMDMPH
287K Followers 4K Following Prof @ucsf, Physician-Scientist, IG @vprasadmdmph @vkprasadlab @plenary_session, YouTube, #vpzd podcast & @Sensible__Med; Views mine
Rachel Cohrs Zhang @rachelcohrs
6K Followers 3K Following Chief Washington Correspondent @statnews. Subscribe to D.C. Diagnosis: https://t.co/t19n377jX6 ✉️: [email protected]
Ben Fidler @BentheFidler
8K Followers 544 Following Biotech Journalist; Senior Editor, BioPharma Dive. Former Deputy Biotech Editor, Xconomy.
Joe Y Chang @JoeChangMD
2K Followers 287 Following Texas 4000 Distinguished Professor and Director, Stereotactic Ablative Radiotherapy Program, MD Anderson Cancer Center
Saad Z. Usmani MD MBA.. @szusmani
11K Followers 615 Following Chief of Myeloma @MSKCancerCenter | Chair @ALLIANCE_org #mmsm Com | MD ≠ Provider| @ASH_hematology @ASTCT @ASCO |married to @ZainabShd | #BMTsm #CARTsm #CureMM
C. Ola Landgren, M.D. @DrOlaLandgren
11K Followers 91 Following Professor of Medicine, Chief of Myeloma Division & Translational Clinical Oncology Program. Sylvester Comprehensive Cancer Center, Univ of Miami. Tweets = mine
Brian Klaas @brianklaas
262K Followers 997 Following Associate Professor in Global Politics @UCL. Author of “Fluke” / “Corruptible”. Writer @TheAtlantic. Host @PowrCorrupts. The Garden of Forking Paths Substack.
ISCT @ISCTglobal
5K Followers 646 Following Driving the translation of cell & gene therapies for the benefit of patients worldwide.
Sairah Ahmed MD @sairah__ahmed
1K Followers 807 Following Lymphoma/Cellular Therapy & SCT at MD Anderson Cancer Center, opinions/tweets shared= my own.
Ashley Zehnder @ashleyz413
489 Followers 317 Following A veterinarian-scientist at the intersection of animal biology and human health. I see opportunity at the intersection of genomics and new model organisms!
Dr. Namandjé N. Bump.. @DrBumpusFDA
740 Followers 37 Following Principal Deputy Commissioner & Acting Chief Scientist at the U.S. Food and Drug Administration - @US_FDA
Michael Felberbaum @FDASpox
933 Followers 46 Following Asst. Commissioner for Media Affairs at @US_FDA. Tripawd dog dad. Extremely amateur hockey player.
Andrew Yee, MD @andrew02114
1K Followers 632 Following Medical oncologist at @MGHCancerCenter, Asst. Prof. of Medicine @harvardmed, focusing on patient care and trials in multiple myeloma and plasma cell disorders.
Hira Mian @HiraSMian
1K Followers 327 Following Multiple Myeloma Lead, Juravinski Cancer Centre Clinical Investigator Assistant Professor, McMaster University
Gritstone bio @gritstonebio
1K Followers 209 Following Gritstone bio is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines for cancer and infectious disease
David Mitchell @DavidP4AD
5K Followers 1K Following Diagnosed w/multiple myeloma 2010. Completely dependent on innovation & new drugs for survival. Fighting for affordable prices. Founder: @P4AD_ & @P4ADNOW
Ryan Flinn @RS_Flinn
4K Followers 5K Following Comms consultant with 20+ years of experience in PR & journalism. Formerly at Resilience, J&J, Bloomberg. Bylines w/NYT, SFGate, AJMC.
Carl Icahn @Carl_C_Icahn
464K Followers 108 Following Chairman of Icahn Enterprises L.P.; etc., etc. Some people get rich studying artificial intelligence. Me, I make money studying natural stupidity.
Herbert Loong @herbloong
4K Followers 2K Following academic medical oncologist @ Hong Kong with interests in sarcoma medical oncology, neuro-oncology, thoracic oncology and phase 1 clinical trials.
Roivant Sciences @Roivant
2K Followers 122 Following Roivant aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter
ESMO - Eur. Oncology @myESMO
75K Followers 874 Following The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
Byung-June Park @onco_park
1K Followers 6 Following Biotech & 💊 innovative drugs. Focused on 🔬 oncology. Expert in 📊 market & industry analysis. #NewDrugs #BioInsights #LetsConnect
kristieneo @kristieneo
1K Followers 777 Following Venture capital editor/reporter at DealStreetAsia. Ex-CNBC, CNA, We Are Social. Asian Civilisations Museum on weekends. Hello!🍹
Rafael Fonseca MD �.. @Rfonsi1
15K Followers 2K Following Chief Innovation Officer - Mayo Clinic in Arizona. Myeloma doctor. Visiting Healthcare Fellow @GoldwaterInst. Tweets-own/RT not an endorsement
Portage Biotech @PortageBiotech
520 Followers 124 Following Portage Biotech is developing first-in-class immuno-oncology therapies to help more patients achieve durable treatment responses and a better quality of life.
Eric Sagonowsky @EricSFierce
608 Followers 40 Following Senior Editor for the Fierce life sciences group.
Albert Sek, Ph.D. @AlbertSek
291 Followers 618 Following 👨🏫 Regulatory / Labeling professional @ Merck, helping to bring life-saving medicines to patients around the world. Views are my own. 📚UCLA, UC Davis, NIH.
John T. Bresnahan @john_bresnahan
2K Followers 981 Following
John Herrmann, PhD @ablT315I
1K Followers 950 Following Cancer biologist / biotech strategy guy turned VC — helping amazing biotech founders reimagine new medicines for patients in need & navigate what’s next.
Fyodor Urnov @UrnovFyodor
15K Followers 533 Following Gene editor + Professor of Molecular Therapeutics @berkeleyMCB + Director of @igisci @danahercorp Beacon for CRISPR Cures.
ROME Therapeutics @rome_tx
383 Followers 94 Following We are developing novel therapies for cancer and autoimmune diseases by unlocking the role of the dark genome in human health and disease
Noah Tong @Tong_Thoughts
462 Followers 648 Following Staff writer covering health payers for @FierceHealth. Past: @CBJournal, former sports reporter. Based in Chicago. Find me at [email protected]
David R. Wilson @DavidRWilson
1K Followers 613 Following Biotech, gene delivery & science. Head of RNA Discovery developing vaccines. PhD from @JHUBME. He/His.
LiveSquawk @LiveSquawk
284K Followers 2K Following Up-to-the-second financial markets news. Try our audio squawk service today: https://t.co/vzxJlLhRIv
Arjun Raj @arjunrajlab
25K Followers 2K Following Just another LLM. Tweets do not necessarily reflect the views of people in my lab or even my own views last week. https://t.co/fZAnUCqd12
Katie Engleman @katie_engleman
579 Followers 867 Following @1abmedia managing director. All things biotech. Dog mom to Dingo the pug, Riggins the boxer, Derby the horse.
Anastassia Gliadkovsk.. @gliadkovskaya
2K Followers 718 Following Covering health equity @FierceHealth. Ex Stabile @ColumbiaJourn @PulitzerCenter @Forbes @THECITYNY. 📥 [email protected]
Nathan A. Pennell MD,.. @n8pennell
13K Followers 1K Following Professor and thoracic oncologist, Vice Chair Clin Res @ClevelandClinic Cancer Inst, @ASCO #EdBook Editor in Chief, Dad, Steelers fan. All opinions mine. #LCSM
Charu Aggarwal, MD, M.. @CharuAggarwalMD
11K Followers 2K Following Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl
Angie DeMichele, MD, .. @AngieDemichele
854 Followers 221 Following Miller Professor and Co-Leader, Breast Cancer Program, Abramson Cancer Center, University of Pennsylvania
Asian American Journa.. @aaja
30K Followers 4K Following 43 Years of #AAJAFamily & #AAJAKudos | Diversity in news industry & newsroom coverage | Innovation, leadership & training | @AAJACareers | #AAJA24 | https://t.co/xnpGftCUh3
Ayla Ellison @AylaEllison
3K Followers 1K Following Editor-in-Chief, Healthcare & Life Sciences, at Questex @FierceBiotech @FierceHealth @FiercePharma @FierceMedtech
Denise Heady @dheady8
634 Followers 1K Following Science Communications & Media Relations Manager @UCLAJCCC. Big sweet tooth. Breakfast person. Viva Los Doyers. Views are my own.
Lidia Schapira @l_schapira
1K Followers 304 Following Medical Oncologist at Stanford and Editor-in-Chief of https://t.co/BkkPHkXdSK.
Also a very nice quote by @PlasmaCellPete about what MRD can bring to the table in #MMsm - I'm excited to hear how the ODAC goes! And thanks @Angus_Fierce @FierceBiotech for discussing this important topic.
Team Fauna on-site at #JPM24 and #BiotechShowcase24 this week! Our CEO @ashleyz413 was on a #metabesity panel moderated by @FierceBiotech @Angus_Fierce 🔥🔥
This was an awesome and wonderfully personal report. Kudos @Angus_Fierce
A few months ago, Fierce asked employees working in the biopharma industry to use photographs to tell their stories during the COVID-19 pandemic. Now, we’re showcasing those memories here. fiercepharma.com/pharma/biotech…
This marks the first time that a PD-1/L1 inhibitor has demonstrated an overall survival benefit in first-line endometrial cancer-- according to @Angus_Fierce story below incl interview with GSK’s head of oncology clinical development Hesham Abdullah, M.D.
Adding GSK's PD-1 inhibitor Jemperli to chemotherapy significantly extended the life spans of patients with primary advanced or first recurrent endometrial cancer in phase 3 RUBY trial, GSK said Monday. fiercepharma.com/pharma/gsks-je…
#ICYMI our CEO, Dr. Ian Walters was featured as an expert panelist along with other industry leaders at #BIO2023 to discuss #CheckpointInhibitors & progress in the #ImmunoOncology space, moderated by @Angus_Fierce of @FierceBiotech. Learn more here: brnw.ch/21wBDcM
June was a big month. 1 launch 28 videos 6+ hours of footage 100% biotech And it’s just a start. Thanks for watching BiotechTV and for your support!
Bringing the biotech sector to life. biotechtv.com
i-spy @Angus_Fierce from the BIO overflow room!
what in the 52 degrees is going on right now
What a great group of leaders recognized in the @FiercePharma most influential people in #biotech & #pharma including our Founder & CEO @daphnezohar. Check it out here: fiercepharma.com/special-report…
Angus flipped a switch at 9pm on a Friday to bring you this critical news. This trial tells you how much pharmas are angling for pole position in this market.
Eli Lilly quietly unveiled a #Mounjaro head-to-head trial against Novo Nordisk's #Wegovy. It's game on between the two drugmakers in #obesity: fiercepharma.com/pharma/heavywe…
@BiotechCH @SamFazeli8 I was at ASCO that year and know exactly what you are talking about. Here is one minority report that gave the data the benefits of doubt by @Angus_Fierce fiercebiotech.com/biotech/asco-d…
It’s not often you see a hazard ratio below .30. The new treatment paradigm that BCMA cell therapies are opening up in multiple myeloma is truly historic and spectacular. Get that vector shortage figured out! fiercepharma.com/pharma/leaked-…
Pleasure to interview @UrviShahMD on behalf of @ASTCT 🎙️! Easy to answer 'why' bsAbs in #MMsm, but who/what/when/where harder: pt selection, ID PPx, CMV quants (?), time-limited Tx, community sites, & more. 🙏 Dr. Shah for sharing her awesome insights! nucleus.astct.org/Full-Article/b…
"The @scynexis deal marks the third major act for @GSK in the antimicrobial field in less than a year. fiercepharma.com/pharma/gsk-sal…" by @Angus_Fierce.
This week on 'The Top Line', @Angus_Fierce and Michael Atkins, M.D., sat down to discuss a checklist that SITC released for running phase 3 cancer immunotherapy combination studies. Plus, the week's biggest headlines. tinyurl.com/43wvj528
Taking a comprehensive approach to executing our “U.S.-first” #strategy is discussed by Victor Bulto. This focus includes early research, drug profile selection, clinical development, commercialization and patient services. @FiercePharma #Investors #JPM23 bit.ly/3ZKvlK1
*taps mic* anyone still use this app? if you do + you'll be at #JPM23/Biotech Showcase, come to the closing plenary! I'll be there for @BioPharmaDive, chatting with @cglifeagency's Erik Clausen, @ArmstrongDrew, @ADeAngelis_bio, @ScripMandy, @rleuty_biotech + @Angus_Fierce.
So excited to be working with this team! Let me know what kinds of stories you want to hear about, especially if they're about shopping or sovereign debt or celebrity gossip or data privacy or D&D or what kind of emoji I should/shouldn't be using 👍👍👍👍👍👍
The Indicator from Planet Money names three co-hosts @VelocityWong, @DarianWoods & @ManyAdrians npr.org/about-npr/1128…
Grateful to @FierceBiotech and @Angus_Fierce for the opportunity to share the stage as part of a recent panel on the progress and future of #genetic medicine.
CRISPR “democratized” gene editing. Now, biopharma companies are turning the tools into therapeutics. fiercebiotech.com/biotech/gene-e…
Trends for United States
You might like
